Study designs in paediatric pharmacoepidemiology

European Journal of Clinical Pharmacology

Volumn 67, Issue SUPPL. 1, 2011, Pages

  Verhamme, Katia ^a,b   Sturkenboom, Miriam ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Case control; Children; Cohort; Effectiveness; Pharmacoepidemiology; Safety

Indexed keywords

ADVERSE OUTCOME; AGE; CASE CONTROL STUDY; CASE STUDY; CHILD CARE; CHILD SAFETY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DRUG EXPOSURE; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; OBSERVATIONAL STUDY; OFF LABEL DRUG USE; PEDIATRICS; PHARMACOEPIDEMIOLOGY; PREGNANCY; PRIORITY JOURNAL; REFERENCE DATABASE; REVIEW; SEX DIFFERENCE; STUDY DESIGN; TREATMENT OUTCOME;

CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; HUMANS; PEDIATRICS; PHARMACOEPIDEMIOLOGY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 79955615237     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0930-2     Document Type: Review

References (46)

1. World Health Organization (2007) Promoting safety of medicines in children. WHO Press, Geneva
2. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology - drug disposition, action, and therapy in infants and children. N Engl J Med 349(12):1157-1167 (Pubitemid 37122329)
3. EMEA www.emea.europe.eu
4. FDA. Paediatric drug development. http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/DevelopmentResources/ucm049867.htm
5. EMEA. Medicines for children - EU paediatric network. www.emea.europa.eu/htms/human/paediatrics.network.htm
6. EMEA. Inventory of paediatric needs. http://www.ema.europa.eu/ema/index
7. Hartzema AG, Tilson HH, Chan KA (2008) Pharmacoepidemiology and therapeutic risk management. Whitney, Cincinnati, OH
8. Strom BL, Kimmel SE (2006) Textbook of pharmacoepidemiology. Wiley, New York
9. TEDDY, www.teddynoe.org
10. Taussig HB (1962) A study of the German outbreak of phocomelia. The thalidomide syndrome. JAMA 180:1106-1114
11. Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284(15):878-881
12. Graham DJ, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray WA (2005) Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet 365(9458):475-481 (Pubitemid 40215729)
13. Hippisley-Cox J, Coupland C (2005) Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 330(7504):1366
14. Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT (2005) Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med 165(9):978-984 (Pubitemid 40638117)
15. Levesque LE, Brophy JM, Zhang B (2005) The risk for myocardial infarctionwith cyclooxygenase-2 inhibitors: a population study of elderly adults. Ann Intern Med 142(7):481-489
16. Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR (2002) COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet 360(9339):1071-1073
17. Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J (2004) Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109(17):2068-2073 (Pubitemid 38620213)
18. Torrence ME (1997) Understanding epidemiology. Mosby, St. Louis, MI
19. Caine ED, Margolin DI, Brown GL, Ebert MH (1978) Gilles de la Tourette's syndrome, tardive dyskinesia, and psychosis in an adolescent. Am J Psychiatry 135(2):241-243 (Pubitemid 8275423)
20. Mizrahi EM, Holtzman D, Tharp B (1980) Haloperidol-induced tardive dyskinesia in a child with Gilles de la Tourette's disease. Arch Neurol 37(12):780 (Pubitemid 11213323)
21. Petty LK, Spar CJ (1980) Haloperidol-induced tardive dyskinesia in a 10-year-old girl. Am J Psychiatry 137(6):745-746 (Pubitemid 10121016)
22. Likasitwattanakul S (2005) Serotonin syndrome: a case report. J Med Assoc Thai 88(7):993-996
23. Phan H, Casavant MJ, Crockett S, Lee A, Hall MW, Nahata MC (2008) Serotonin syndrome following a single 50 mg dose of sertraline in a child. Clin Toxicol (Phila) 46(9):845-849
24. Ziaee V, Akbari Hamed E, Hoshmand A, Amini H, Kebriaeizadeh A, Saman K (2005) Side effects of dextromethorphan abuse, a case series. Addict Behav 30(8):1607-1613 (Pubitemid 41191305)
25. Lin S, Gomez MI, Hwang SA, Munsie JP, Fitzgerald EF (2008) Self-reported home environmental risk factors for childhood asthma: a cross-sectional study of children in Buffalo, New York. J Asthma 45(4):325-332 (Pubitemid 351630921)
26. Liberman JN, Berger JE, Lewis M (2009) Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents. Arch Pediatr Adolesc Med 163(4):357-364
27. Ashby D (2008) Establishing causality in the assessment of safety of medicines for children. Acta Paediatr 97(12):1611-1616
28. Luo X, Doherty J, Cappelleri JC, Frush K (2007) Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics. Curr Med Res Opin 23(11):2607-2615 (Pubitemid 350146397)
29. van Staa TP, Bishop N, Leufkens HG, Cooper C (2004) Are inhaled corticosteroids associated with an increased risk of fracture in children? Osteoporos Int 15(10):785-791
30. Sturkenboom M, Nicolosi A, Cantarutti L, Mannino S, Picelli G, Scamarcia A, Giaquinto C; NSAIDs Paediatric Research Group (2005) Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Pediatrics 116(1):e26-e33
31. Furu K, Skurtveit S, Langhammer A, Nafstad P (2007) Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis. Eur J Clin Pharmacol 63(7):693-698 (Pubitemid 46911340)
32. Fox MH, Foster CH, Zito JM (2000) Building pharmacoepidemiological capacity to monitor psychotropic drug use among children enrolled in Medicaid. Am J Med Qual 15(4):126-136
33. Hugtenburg JG, Heerdink ER, Egberts AC (2004) Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol 60(5):377-379 (Pubitemid 39062326)
34. Thrane N, Sorensen HT (1999) A one-year population-based study of drug prescriptions for Danish children. Acta Paediatr 88(10):1131-1136 (Pubitemid 29489172)
35. Sturkenboom MC, Verhamme KM, Nicolosi A, Murray ML, Neubert A, Caudri D, Picelli G, Sen EF, Giaquinto C, Cantarutti L, Baiardi P, Felisi MG, Ceci A, Wong IC; TEDDY European Network of Excellence (2008) Drug use in children: cohort study in three European countries. BMJ 337:a2245
36. Mikaeloff Y, Kezouh A, Suissa S (2008) Nonsteroidal antiinflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease. Br J Clin Pharmacol 65(2):203-209 (Pubitemid 351171264)
37. Lindquist M, Edwards IR (2001) The WHO programme for International drug monitoring, its database, and the technical support of the Uppsala monitoring center. J Rheumatol 28(5):1180-1187 (Pubitemid 32422612)
38. Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Nicolosi A, Giaquinto C, Ceci A, Wong IC; TEDDY Network of Excellence (2008) Databases for pediatric medicine research in Europe-assessment and critical appraisal. Pharmacoepidemiol Drug Saf 17(12):1155-1167
39. Neubert A, Wong IC, Bonifazi A, Catapano M, Felisi M, Baiardi P, Giaquinto C, Knibbe CA, Sturkenboom MC, Ghaleb MA, Ceci A (2008) Defining off-label and unlicensed use of medicines for children: results of a Delphi survey. Pharmacol Res 58(5-6):316-322
40. Chalumeau M, Gendrel D, Bréart G, Pons G (2004) An example of hospital-based pharmacoepidemiology in paediatrics: tolerance to fluoroquinolones. Arch Pediatr 11(6):500-502 (Pubitemid 38680904)
41. 'T Jong GW, Eland IA, Sturkenboom MC, van den Anker JN, Stricker BH (2002) Unlicensed and off label prescription of drugs to children: population based cohort study. BMJ 324(7349):1313-1314 (Pubitemid 34606775)
42. McIntyre J, Conroy S, Avery A, Corns H, Choonara I (2000) Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 83(6):498-501
43. Evidence of harm from off label or unlicensed medicines in children. www.emea.europe.eu/pdfs/human/phvwp/23591005en.pdf
44. EMEA. ICH Topic E 11: Clinical Investigation of Medicinal Products in the Paediatric Population. www.emea.europa.eu/pdfs/human/ich/271199en.pdf
45. Almqvist C, Worm M, Leynaert B (2008) Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy 63(1):47-57 (Pubitemid 350198234)
46. Colvin L, Slack-Smith L, Stanley FJ, Bower C (2009) Pharmacovigilance in pregnancy using population-based linked datasets. Pharmacoepidemiol Drug Saf 18(3):211-225